Twist Bioscience Income Statement

Financials in millions USD. Fiscal year is October - September.

Millions USD. Fiscal year is Oct - Sep.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Sep '25 Sep 30, 2025	Sep '24 Sep 30, 2024	Sep '23 Sep 30, 2023	Sep '22 Sep 30, 2022	Sep '21 Sep 30, 2021
Revenue	391.56	376.57	312.97	245.11	203.57	132.33
Revenue Growth (YoY)	18.59%	20.32%	27.69%	20.41%	53.83%	46.87%
Cost of Revenue	189.42	185.57	179.63	155.38	119.33	80.62
Gross Profit	202.13	191	133.35	89.73	84.24	51.71
Selling, General & Admin	260.54	246.98	218.4	189.74	212.95	135.9
Research & Development	76.11	80.29	90.85	106.89	120.31	69.07
Operating Expenses	336.65	327.26	309.25	296.63	333.26	204.97
Operating Income	-134.52	-136.26	-175.9	-206.9	-249.02	-153.26
Interest Expense	-	-	-	-	-0.08	-0.37
Interest & Investment Income	10.3	11.36	15.34	14.37	3.06	0.44
Other Non Operating Income (Expenses)	-0.34	-0.9	-2.68	-0.67	-1.09	-
EBT Excluding Unusual Items	-124.56	-125.8	-163.24	-193.21	-247.13	-153.19
Merger & Restructuring Charges	-	-	-	-9.38	-	-
Gain (Loss) on Sale of Assets	48.85	48.85	-	-	4.61	-
Asset Writedown	-	-	-44.93	-6.79	-	-
Other Unusual Items	-	-	-	5.91	14.25	-0.84
Pretax Income	-75.71	-76.95	-208.17	-203.47	-228.27	-154.03
Income Tax Expense	0.88	0.72	0.56	1.15	-10.41	-1.93
Net Income	-76.58	-77.67	-208.73	-204.62	-217.86	-152.1
Net Income to Common	-76.58	-77.67	-208.73	-204.62	-217.86	-152.1
Shares Outstanding (Basic)	60	60	58	57	54	48
Shares Outstanding (Diluted)	60	60	58	57	54	48
Shares Change (YoY)	3.17%	3.09%	1.99%	5.57%	11.68%	23.12%
EPS (Basic)	-1.27	-1.30	-3.60	-3.60	-4.04	-3.15
EPS (Diluted)	-1.27	-1.30	-3.60	-3.60	-4.04	-3.15
Free Cash Flow	-86.72	-75.63	-69.17	-170.25	-226.24	-139.31
Free Cash Flow Per Share	-1.44	-1.26	-1.19	-2.99	-4.20	-2.89
Gross Margin	51.62%	50.72%	42.61%	36.61%	41.38%	39.08%
Operating Margin	-34.35%	-36.18%	-56.20%	-84.41%	-122.33%	-115.81%
Profit Margin	-19.56%	-20.63%	-66.69%	-83.48%	-107.02%	-114.94%
Free Cash Flow Margin	-22.15%	-20.08%	-22.10%	-69.46%	-111.14%	-105.27%
EBITDA	-112.75	-114.31	-147.07	-177.59	-232.51	-143.51
EBITDA Margin	-28.79%	-30.35%	-46.99%	-72.45%	-114.22%	-108.45%
D&A For EBITDA	21.77	21.95	28.83	29.31	16.51	9.75
EBIT	-134.52	-136.26	-175.9	-206.9	-249.02	-153.26
EBIT Margin	-34.35%	-36.18%	-56.20%	-84.41%	-122.33%	-115.81%
Advertising Expenses	-	7	5.2	2.9	2.4	2.5

Updated Feb 2, 2026. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q